Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada

PURPOSE: People with cancer face an elevated risk of infection and severe sequelae from COVID-19. Dexamethasone is commonly used for antiemetic prophylaxis with systemic therapy for cancer. However, dexamethasone is associated with increased risk of viral and respiratory infections, and causes lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Grant, Robert C., Rotstein, Coleman, Liu, Geoffrey, Forbes, Leta, Vu, Kathy, Lee, Roy, Ng, Pamela, Krzyzanowska, Monika, Warr, David, Knox, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324309/
https://www.ncbi.nlm.nih.gov/pubmed/32601854
http://dx.doi.org/10.1007/s00520-020-05588-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324309/
https://www.ncbi.nlm.nih.gov/pubmed/32601854
http://dx.doi.org/10.1007/s00520-020-05588-6

Ejemplares similares